id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-V-0192-0004,FDA,FDA-2021-V-0192,Digital projection Variance 2021-V-0192 part number update,Supporting & Related Material,Background Material,2021-12-20T05:00:00Z,2021,12,,,2021-12-20T21:09:19Z,,0,0,0900006484ed701d
FDA-2021-V-0192-0003,FDA,FDA-2021-V-0192,Variance Approval Letter from FDA CDRH to Digital Projection Inc,Other,Approval for Variance (VRA),2021-03-22T04:00:00Z,2021,3,2021-03-22T04:00:00Z,,2021-03-22T13:13:39Z,,0,0,0900006484a73d1d
FDA-2021-V-0192-0001,FDA,FDA-2021-V-0192,Variance Application from Digital Projection Inc,Other,Application for Variance (VAR),2021-02-16T05:00:00Z,2021,2,2021-02-16T05:00:00Z,,2021-02-16T19:56:03Z,,0,0,0900006484a387a5
FDA-2021-V-0192-0002,FDA,FDA-2021-V-0192,Acknowledgment Letter from FDA DMS to Digital Projection Inc,Other,Acknowledgement Letter/Receipt,2021-02-16T05:00:00Z,2021,2,2021-02-16T05:00:00Z,,2021-02-16T19:57:51Z,,0,0,0900006484a387a9